Oral adverse effects of head and neck radiotherapy: Literature review and suggestion of a clinical oral care guideline for irradiated patients

Journal of Applied Oral Science

Volumn 19, Issue 5, 2011, Pages 448-454

  Tolentino, Elen de Souza ^a   Centurion, Bruna Stuchi ^a   Ferreira, Lúcia Helena Caetano ^a   de Souza, Andréia Pereira ^a   Damante, José Humberto ^a   Rubira Bullen, Izabel Regina Fischer ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Head and neck neoplasms; Mucositis; Osteoradionecrosis; Radiation effects; Radiotherapy; Xerostomia

Indexed keywords

EID: 80053909033     PISSN: 16787757     EISSN: 16787765     Source Type: Journal    
DOI: 10.1590/S1678-77572011000500003     Document Type: Article

References (35)

1. Andrews N, Griffiths C. Dental complications of head and neck radiotherapy: Part 2. Aust Dent J. 2001;46(3):174-82.
2. Curi MM, Cossolin GS, Koga DH, Araujo SR, Feher O, Santos MO, et al. Treatment of avascular osteonecrosis of the mandible in cancer patients with a history of bisphosphonate therapy by combining bone resection and autologous platelet-rich plasma: report of 3 cases. J Oral Maxillofac Surg. 2007;65(2):349-55.
3. Delanian S, Lefaix JL. The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway. Radiother Oncol. 2004;73(2):119-31.
4. Denys D, Kaste SC, Kun LE, Chaudhary MA, Bowman LC, Robbins KT. The effects of radiation on craniofacial skeletal growth: a quantitative study. Int J Pediatr Otorhinolaryngol. 1998;45(1):7-13.
5. Dijkstra PU, Kalk WW, Roodenburg JL. Trismus in head and neck oncology: a systematic review. Oral Oncol. 2004;40(9):879-89.
6. Dörr W, Hamilton CS, Boyd T, Reed B, Denham JW. Radiation-induced changes in cellularity and proliferation in human oral mucosa. Int J Radiat Oncol Biol Phys. 2002;52(4):911-7.
7. Duggal MS. Root surface areas in long-term survivors of childhood cancer. Oral Oncol. 2003;39(2):178-83.
8. Garnett MJ, Nohl FS, Barclay SC. Management of patients with reduced oral aperture and mandibular hypomobility (trismus) and implications for operative dentistry. Br Dent J. 2008;204(3):125-31.
9. Gornitsky M, Shenouda G, Sultanem K, Katz H, Hier M, Black M, et al. Double-blind randomized, placebo-controlled study of pilocarpine to salvage salivary gland function during radiotherapy of patients with head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;98(1):45-52.
10. Hancock PJ, Epstein JB, Sadler GR. Oral and dental management related to radiation therapy for head and neck cancer. J Can Dent Assoc. 2003;69(9):585-90.
11. Henk JM, Smith CW. Radiotherapy and hyperbaric-oxygen in head and neck cancer. Interim report of second clinical trial. Lancet. 1977;2(8029):104-5.
12. Jereczek-Fossa BA, Orecchia R. Radiotherapy-induced mandibular bone complications. Cancer Treat Rev. 2002;28(1):65-74.
13. Johnson JT, Ferretti GA, Nethery WJ, Valdez IH, Fox PC, Ng D, et al. Oral pilocarpine for post-irradiation xerostomia in patients with head and neck cancer. N Engl J Med. 1993;329(6):290-5.
14. Ko C, Citrin D. Radiotherapy for the management of locally advanced squamous cell carcinoma of the head and neck. Oral Dis. 2009;15(2):121-32.
15. Koga DH, Salvajoli JV, Alves FA. Dental extractions and radiotherapy in head and neck oncology: review of the literature. Oral Dis. 2008;14(1):40-4.
16. Konings AW, Coppes RP, Vissink A. On the mechanism of salivary gland radiosensitivity. Int J Radiat Oncol Biol Phys. 2005;62(4):1187-94.
17. Köstler WJ, Hejna M, Wenzel C, Zielinski CC. Oral mucositis complicating chemotherapy and/or radiotherapy: options for prevention and treatment. CA Cancer J Clin. 2001;51(5):290-315.
18. Mitchell MJ, Logan PM. Radiation-induced changes in bone. Radiographics. 1998;18(5):1125-36.
19. Möller P, Perrier M, Ozsahin M, Monnier P. A prospective study of salivary gland function in patients undergoing radiotherapy for squamous cell carcinoma of the oropharynx. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004;97(2):173-89.
20. Nakamura N, Sasano N, Yamashita H, Igaki H, Shiraishi K, Terahara A, et al. Oral pilocarpine (5 mg t.i.d.) used for xerostomia causes adverse effects in Japanese. Auris Nasus Larynx. 2009;36(3):310-3.
21. Oh HK, Chambers MS, Martin JW, Lim HJ, Park HJ. Osteoradionecrosis of the mandible: treatment outcomes and factors influencing the progress of osteoradionecrosis. J Oral Maxillofac Surg. 2009;67(7):1378-86.
22. Okeson JP. Management of temporomandibular disorders and occlusion. St. Louis: Mosby; 1998.
23. Otmani N. Oral and maxillofacial side effects of radiation therapy on children. J Can Dent Assoc. 2007;73(3):257-61.
24. Paulino AC, Simon JH, Zhen W, Wen BC. Long-term effects in children treated with radiotherapy for head and neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys. 2000;48(5):1489-95.
25. Prott FJ, Handschel J, Micke O, Sunderkötter C, Meyer U, Piffko J. Long-term alterations of oral mucosa in radiotherapy patients. Int J Radiat Oncol Biol Phys. 2002;54(1):203-10.
26. Raney RB, Anderson JR, Kollath J, Vassilopoulou-Sellin R, Klein MJ, Heyn R, et al. Late effects of therapy in 94 patients with localized rhabdomyosarcoma of the orbit: report from the Intergroup Rhabdomyosarcoma Study (IRS)-III, 1984-1991. Med Pediatr Oncol. 2000;34(6):413-20.
27. Rosales AC, Esteves SC, Jorge J, Almeida OP, Lopes MA. Dental needs in Brazilian patients subjected to head and neck radiotherapy. Braz Dent J. 2009;20(1):74-7.
28. Rubira CM, Devides NJ, Ubeda LT, Bortolucci AG Jr, Lauris JR, Rubira-Bullen IR, et al. Evaluation of some oral postradiotherapy sequelae in patients treated for head and neck tumors. Braz Oral Res. 2007;21(3):272-7.
29. Sandoval RL, Koga DH, Buloto LS, Suzuki R, Dib LL. Management of chemo-and radiotherapy induced oral mucositis with low-energy laser: initial results of A.C. Camargo Hospital. J Appl Oral Sci. 2003;11(4):337-41.
30. Steelman R, Sokol J. Quantification of trismus following irradiation of the temporomandibular joint. Mo Dent J. 1986;66(6):21-3.
31. Teng MS, Futran ND. Osteoradionecrosis of the mandible. Curr Opin Otolaryngol Head Neck Surg. 2005;13(4):217-21.
32. Thomas F, Ozanne F, Mamelle G, Wibault P, Eschwege F. Radiotherapy alone for oropharyngeal carcinomas: the role of fraction size (2 Gy vs 2.5 Gy) on local control and early and late complications. Int J Radiat Oncol Biol Phys. 1988;15(5):1097-102.
33. Vissink A, Jansma J, Spijkervet FK, Burlage FR, Coppes RP. Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med. 2003;14(3):199-212.
34. Watson ER, Halnan KE, Dische S, Saunders MI, Cade IS, McEwen JB, et al. Hyperbaric oxygen and radiotherapy: a Medical Research Council trial in carcinoma of the cervix. Br J Radiol. 1978;51(611):879-87.
35. White SC, Pharoah MJ. Oral radiology: principles and Interpretation. St. Louis: Mosby; 2004.